Immuno-oncology market set to grow in billions, but access concerns remain
Pharmaceutical Technology
MAY 26, 2023
The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028.
Let's personalize your content